Skip to content
OpenCapital
Get started

Proto Labs PRLB Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

OTT
Otter TailOTTR
$78.56M+577%
Kennametal logo
KennametalKMT
-$560K+98.1%
Benchmark Electronics logo
Benchmark ElectronicsBHE
-$25.9M-949%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
——

Other financials

Income statement

See full
Revenue$139.3M+10.4%
Gross profit$63.6M+14.2%
Operating income$9.8M+117%
Net income$8.1M+125%
EPS (diluted)$0.33+120%

Balance sheet

See full
Cash & equivalents$124.0M+49.9%
Total debt$2.6M-16.6%
Total equity$683.1M+4.0%
Total assets$778.6M+5.6%

Cash flow

See full
Operating cash flow$17.5M-4.6%
CapEx$3.5M+181%
Free cash flow$14.0M-18.2%

Valuation

See full
Market cap$1.9B+59.7%

Profitability

See full
Gross margin44.9%+0.5pp
Operating margin5.6%+1.7pp
Net margin4.7%+1.6pp
FCF margin10.4%-3.1pp

Returns & leverage

See full
Return on equity3.8%+1.6pp
Debt / equity0×0.0×
Current ratio3.5×+0.4×

Where this comes from

Reported directly by Proto Labs in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Proto Labs’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Proto Labs's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Proto Labs's cash provided by (used in) financing activity, including discontinued operation?
Proto Labs (PRLB) reported cash provided by (used in) financing activity, including discontinued operation of $658K in Q1 2026.
How has Proto Labs's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
Proto Labs's cash provided by (used in) financing activity, including discontinued operation increased by 103.0% year-over-year, from -$21.93M to $658K.
What is the long-term trend for Proto Labs's cash provided by (used in) financing activity, including discontinued operation?
Over 4 years (2021 to 2025), Proto Labs's cash provided by (used in) financing activity, including discontinued operation has grown at a 16.1% compound annual growth rate (CAGR), from -$22.2M to -$40.37M.
What does cash provided by (used in) financing activity, including discontinued operation mean?
This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.